Jefferies analyst Andrew Tsai reiterated a Buy rating and $335.00 price target on Vertex (NASDAQ: VRTX) after the FDA removed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE